The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Embolization Particle-Global Market Insights and Sales Trends 2025
Synopsis
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global Embolization Particle market size is expected to reach US$ 5248.9 million by 2029, growing at a CAGR of 14.5% from 2023 to 2029. The market is mainly driven by the significant applications of Embolization Particle in various end use industries. The expanding demands from the Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization and Trauma Embolization, are propelling Embolization Particle market. Microspheres, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Particles (e.g. PVA Particles, Gelfoam Particles) segment is estimated at % CAGR for the next seven-year period.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Embolization Particle market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Embolization Particle market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Embolization Particle sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Embolization Particle covered in this report include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V. and Alicon, etc.
The global Embolization Particle market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Global Embolization Particle market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Embolization Particle market, Segment by Type:
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Global Embolization Particle market, by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global Embolization Particle market size is expected to reach US$ 5248.9 million by 2029, growing at a CAGR of 14.5% from 2023 to 2029. The market is mainly driven by the significant applications of Embolization Particle in various end use industries. The expanding demands from the Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization and Trauma Embolization, are propelling Embolization Particle market. Microspheres, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Particles (e.g. PVA Particles, Gelfoam Particles) segment is estimated at % CAGR for the next seven-year period.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Embolization Particle market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Embolization Particle market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Embolization Particle sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Embolization Particle covered in this report include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V. and Alicon, etc.
The global Embolization Particle market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Global Embolization Particle market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Embolization Particle market, Segment by Type:
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Global Embolization Particle market, by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Embolization Particle Market Overview
1.1 Embolization Particle Product Overview
1.2 Embolization Particle Market Segment by Type
1.2.1 Microspheres
1.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.3 Drug-eluting Beads (DEBs)
1.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Global Embolization Particle Market Size by Type
1.3.1 Global Embolization Particle Market Size Overview by Type (2018-2029)
1.3.2 Global Embolization Particle Historic Market Size Review by Type (2018-2023)
1.3.3 Global Embolization Particle Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Embolization Particle Sales Breakdown by Type (2018-2023)
1.4.2 Europe Embolization Particle Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Embolization Particle Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Embolization Particle Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Embolization Particle Sales Breakdown by Type (2018-2023)
2 Global Embolization Particle Market Competition by Company
2.1 Global Top Players by Embolization Particle Sales (2018-2023)
2.2 Global Top Players by Embolization Particle Revenue (2018-2023)
2.3 Global Top Players by Embolization Particle Price (2018-2023)
2.4 Global Top Manufacturers Embolization Particle Manufacturing Base Distribution, Sales Area, Product Type
2.5 Embolization Particle Market Competitive Situation and Trends
2.5.1 Embolization Particle Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Embolization Particle Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Embolization Particle as of 2022)
2.7 Date of Key Manufacturers Enter into Embolization Particle Market
2.8 Key Manufacturers Embolization Particle Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Embolization Particle Status and Outlook by Region
3.1 Global Embolization Particle Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Embolization Particle Historic Market Size by Region
3.2.1 Global Embolization Particle Sales in Volume by Region (2018-2023)
3.2.2 Global Embolization Particle Sales in Value by Region (2018-2023)
3.2.3 Global Embolization Particle Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Embolization Particle Forecasted Market Size by Region
3.3.1 Global Embolization Particle Sales in Volume by Region (2024-2029)
3.3.2 Global Embolization Particle Sales in Value by Region (2024-2029)
3.3.3 Global Embolization Particle Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Embolization Particle by Application
4.1 Embolization Particle Market Segment by Application
4.1.1 Uterine Fibroid Embolization
4.1.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
4.1.3 Liver Tumor Embolization
4.1.4 Trauma Embolization
4.1.5 Others
4.2 Global Embolization Particle Market Size by Application
4.2.1 Global Embolization Particle Market Size Overview by Application (2018-2029)
4.2.2 Global Embolization Particle Historic Market Size Review by Application (2018-2023)
4.2.3 Global Embolization Particle Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Embolization Particle Sales Breakdown by Application (2018-2023)
4.3.2 Europe Embolization Particle Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Embolization Particle Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Embolization Particle Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Embolization Particle Sales Breakdown by Application (2018-2023)
5 North America Embolization Particle by Country
5.1 North America Embolization Particle Historic Market Size by Country
5.1.1 North America Embolization Particle Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Embolization Particle Sales in Volume by Country (2018-2023)
5.1.3 North America Embolization Particle Sales in Value by Country (2018-2023)
5.2 North America Embolization Particle Forecasted Market Size by Country
5.2.1 North America Embolization Particle Sales in Volume by Country (2024-2029)
5.2.2 North America Embolization Particle Sales in Value by Country (2024-2029)
6 Europe Embolization Particle by Country
6.1 Europe Embolization Particle Historic Market Size by Country
6.1.1 Europe Embolization Particle Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Embolization Particle Sales in Volume by Country (2018-2023)
6.1.3 Europe Embolization Particle Sales in Value by Country (2018-2023)
6.2 Europe Embolization Particle Forecasted Market Size by Country
6.2.1 Europe Embolization Particle Sales in Volume by Country (2024-2029)
6.2.2 Europe Embolization Particle Sales in Value by Country (2024-2029)
7 Asia-Pacific Embolization Particle by Region
7.1 Asia-Pacific Embolization Particle Historic Market Size by Region
7.1.1 Asia-Pacific Embolization Particle Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Embolization Particle Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Embolization Particle Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Embolization Particle Forecasted Market Size by Region
7.2.1 Asia-Pacific Embolization Particle Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Embolization Particle Sales in Value by Region (2024-2029)
8 Latin America Embolization Particle by Country
8.1 Latin America Embolization Particle Historic Market Size by Country
8.1.1 Latin America Embolization Particle Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Embolization Particle Sales in Volume by Country (2018-2023)
8.1.3 Latin America Embolization Particle Sales in Value by Country (2018-2023)
8.2 Latin America Embolization Particle Forecasted Market Size by Country
8.2.1 Latin America Embolization Particle Sales in Volume by Country (2024-2029)
8.2.2 Latin America Embolization Particle Sales in Value by Country (2024-2029)
9 Middle East and Africa Embolization Particle by Country
9.1 Middle East and Africa Embolization Particle Historic Market Size by Country
9.1.1 Middle East and Africa Embolization Particle Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Embolization Particle Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Embolization Particle Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Embolization Particle Forecasted Market Size by Country
9.2.1 Middle East and Africa Embolization Particle Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Embolization Particle Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sirtex Medical
10.1.1 Sirtex Medical Company Information
10.1.2 Sirtex Medical Introduction and Business Overview
10.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sirtex Medical Embolization Particle Products Offered
10.1.5 Sirtex Medical Recent Development
10.2 Merit Medical
10.2.1 Merit Medical Company Information
10.2.2 Merit Medical Introduction and Business Overview
10.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merit Medical Embolization Particle Products Offered
10.2.5 Merit Medical Recent Development
10.3 Cook Medical
10.3.1 Cook Medical Company Information
10.3.2 Cook Medical Introduction and Business Overview
10.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cook Medical Embolization Particle Products Offered
10.3.5 Cook Medical Recent Development
10.4 BTG Medical
10.4.1 BTG Medical Company Information
10.4.2 BTG Medical Introduction and Business Overview
10.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BTG Medical Embolization Particle Products Offered
10.4.5 BTG Medical Recent Development
10.5 Boston Scientific Corporation
10.5.1 Boston Scientific Corporation Company Information
10.5.2 Boston Scientific Corporation Introduction and Business Overview
10.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Boston Scientific Corporation Embolization Particle Products Offered
10.5.5 Boston Scientific Corporation Recent Development
10.6 Terumo Corporation
10.6.1 Terumo Corporation Company Information
10.6.2 Terumo Corporation Introduction and Business Overview
10.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Terumo Corporation Embolization Particle Products Offered
10.6.5 Terumo Corporation Recent Development
10.7 HENGRUI Medical
10.7.1 HENGRUI Medical Company Information
10.7.2 HENGRUI Medical Introduction and Business Overview
10.7.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.7.4 HENGRUI Medical Embolization Particle Products Offered
10.7.5 HENGRUI Medical Recent Development
10.8 INterface BIOmaterials B.V.
10.8.1 INterface BIOmaterials B.V. Company Information
10.8.2 INterface BIOmaterials B.V. Introduction and Business Overview
10.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.8.4 INterface BIOmaterials B.V. Embolization Particle Products Offered
10.8.5 INterface BIOmaterials B.V. Recent Development
10.9 Alicon
10.9.1 Alicon Company Information
10.9.2 Alicon Introduction and Business Overview
10.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Alicon Embolization Particle Products Offered
10.9.5 Alicon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Embolization Particle Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Embolization Particle Industrial Chain Analysis
11.4 Embolization Particle Market Dynamics
11.4.1 Embolization Particle Industry Trends
11.4.2 Embolization Particle Market Drivers
11.4.3 Embolization Particle Market Challenges
11.4.4 Embolization Particle Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Embolization Particle Distributors
12.3 Embolization Particle Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
